Correcting HPV Vaccination Misinformation Online: Evaluating the HPV Vaccination NOW Social Media Campaign
Abstract
:1. Introduction
2. Materials and Methods
2.1. HPV Vaccination NOW
2.2. Campaign Evaluation
2.2.1. Process Evaluation
“HPV Vaccination NOW: This is Our Moment is a new initiative by @sccancerorg and @MUSCHollings. The HPV vaccine protects girls and boys from 6 HPV-related cancers. Make an appointment to get your girls and boys the HPV vaccine today. #HPVvaxNOW #OurMoment http://muschealth.org/hpv” (accessed on 1 January 1 2021)
2.2.2. Qualitative Content Analysis
3. Results
3.1. Process Evaluation
3.2. Content Analysis
3.3. Addressing Misinformation
“Got my son and daughter vaccinated against HPV. I know too many women diagnosed with cervical cancer or pre-cancerous conditions not to want to protect my own kids from this virus. Vaccination rates are much higher in other developed countries while Americans continue to deny the benefits of life saving vaccines to their children over false information and anti-science viewpoints.”
“Worst thing I ever did for my daughter. Made her gain 60 pounds and caused what looks like permanent body aches and has so much trouble sleeping since then. They are terrible, I would never recommend them. Never.”
3.4. Stimulating Peer-to-Peer Dialogue
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Acknowledgments
Conflicts of Interest
References
- Simms, K.T.; Steinberg, J.; Caruana, M.; Smith, M.A.; Lew, J.-B.; Soerjomataram, I.; Castle, P.E.; Bray, F.; Canfell, K. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: A modelling study. Lancet Oncol. 2019, 20, 394–407. [Google Scholar] [CrossRef]
- McClung, N.M.; Gargano, J.W.; Bennett, N.M.; Niccolai, L.M.; Abdullah, N.; Griffin, M.R.; Park, I.U.; Cleveland, A.A.; Querec, T.D.; Unger, E.R.; et al. Trends in Human Papillomavirus Vaccine Types 16 and 18 in Cervical Precancers, 2008–2014. Cancer Epidemiol. Biomark. Prev. 2019, 28, 602–609. [Google Scholar] [CrossRef] [Green Version]
- Bogani, G.; Taverna, F.; Lombardo, C.; Signorelli, M.; Chiappa, V.; Casarin, J.; Scaffa, C.; Maggiore, U.L.R.; Recalcati, D.; Ditto, A.; et al. Potential impact of introducing a nonavalent HPV vaccination. Int. J. Gynecol. Obstet. 2018, 142, 338–342. [Google Scholar] [CrossRef]
- Van Dyne, E.A.; Henley, S.J.; Saraiya, M.; Thomas, C.C.; Markowitz, L.E.; Benard, V.B. Trends in Human Papillomavirus–Associated Cancers—United States, 1999–2015. MMWR. Morb. Mortal. Wkly. Rep. 2018, 67, 918–924. [Google Scholar] [CrossRef] [Green Version]
- Lei, J.; Ploner, A.; Elfström, K.M.; Wang, J.; Roth, A.; Fang, F.; Sundström, K.; Dillner, J.; Sparén, P. HPV Vaccination and the Risk of Invasive Cervical Cancer. New Engl. J. Med. 2020, 383, 1340–1348. [Google Scholar] [CrossRef]
- World Health Organization. Launch of the Global Strategy to Accelerate the Elimination of Cervical Cancer. 2020. Available online: https://www.who.int/news-room/events/detail/2020/11/17/default-calendar/launch-of-the-global-strategy-to-accelerate-the-elimination-of-cervical-cancer (accessed on 1 January 2021).
- Bogani, G.; Serati, M.; Maggiore, U.L.R.; Ditto, A.; Gardella, B.; Ferrero, S.; Spinillo, A.; Ghezzi, F.; Raspagliesi, F. Cervical intraepithelial neoplasia in women who had vaccination against HPV. Int. J. Gynecol. Obstet. 2019, 147, 233–237. [Google Scholar] [CrossRef]
- Beavis, A.; Krakow, M.; Levinson, K.; Rositch, A.F. Reasons for Lack of HPV Vaccine Initiation in NIS-Teen over Time: Shifting the Focus From Gender and Sexuality to Necessity and Safety. J. Adolesc. Health 2018, 63, 652–656. [Google Scholar] [CrossRef] [PubMed]
- Hall, M.T.; Simms, K.T.; Lew, J.-B.; Smith, M.A.; Brotherton, J.M.; Saville, M.; Frazer, I.H.; Canfell, K. The projected timeframe until cervical cancer elimination in Australia: A modelling study. Lancet Public Health 2019, 4, e19–e27. [Google Scholar] [CrossRef] [Green Version]
- Elam-Evans, L.D.; Yankey, D.; Singleton, J.A.; Sterrett, N.; Markowitz, L.E.; Williams, C.L.; Fredua, B.; McNamara, L.; Stokley, S. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2019. MMWR Morb. Mortal. Wkly. Rep. 2020, 69, 1109–1116. [Google Scholar] [CrossRef]
- Sonawane, K.; Zhu, Y.; Montealegre, J.R.; Lairson, D.R.; Bauer, C.; McGee, L.U.; Giuliano, A.R.; Deshmukh, A.A. Parental intent to initiate and complete the human papillomavirus vaccine series in the USA: A nationwide, cross-sectional survey. Lancet Public Health 2020, 5, e484–e492. [Google Scholar] [CrossRef]
- Gilkey, M.B.; Bednarczyk, R.A.; Gerend, M.A.; Kornides, M.L.; Perkins, R.B.; Saslow, D.; Sienko, J.; Zimet, G.D.; Brewer, N.T. Getting Human Papillomavirus Vaccination Back on Track: Protecting Our National Investment in Human Papillomavirus Vaccination in the COVID-19 Era. J. Adolesc. Health 2020, 67, 633–634. [Google Scholar] [CrossRef] [PubMed]
- Mehrotra, A.; Chernew, M.; Linetsky, D.; Hatch, H.; Cutler, D. The Impact of the COVID-19 Pandemic on Outpatient Visits: A Rebound Emerges; To the Point (blog); Commonwealth Fund: New York, NY, USA, 19 May 2020. [Google Scholar] [CrossRef]
- Hull, P. Practical Strategies for Improving HPV Vaccination; Virtual; South Carolina Cancer Alliance: Columbia, SC, USA, 2021. [Google Scholar]
- Zhao, Y.; Zhang, J. Consumer health information seeking in social media: A literature review. Health Inf. Libr. J. 2017, 34, 268–283. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fu, L.Y.; Bonhomme, L.-A.; Cooper, S.C.; Joseph, J.G.; Zimet, G.D. Educational interventions to increase HPV vaccination acceptance: A systematic review. Vaccine 2014, 32, 1901–1920. [Google Scholar] [CrossRef] [Green Version]
- Reiter, P.L.; Gerend, M.A.; Gilkey, M.B.; Perkins, R.B.; Saslow, D.; Stokley, S.; Tiro, J.A.; Zimet, G.D.; Brewer, N.T. Advancing Human Papillomavirus Vaccine Delivery: 12 Priority Research Gaps. Acad. Pediatr. 2018, 18, S14–S16. [Google Scholar] [CrossRef] [Green Version]
- Maher, C.A.; Lewis, L.K.; Ferrar, K.; Marshall, S.; de Bourdeaudhuij, I.; Vandelanotte, C. Are Health Behavior Change Interventions That Use Online Social Networks Effective? A Systematic Review. J. Med Internet Res. 2014, 16, e40. [Google Scholar] [CrossRef] [Green Version]
- Pedersen, E.A.; Loft, L.H.; Jacobsen, S.U.; Søborg, B.; Bigaard, J. Strategic health communication on social media: Insights from a Danish social media campaign to address HPV vaccination hesitancy. Vaccine 2020, 38, 4909–4915. [Google Scholar] [CrossRef]
- Loft, L.H.; Pedersen, E.A.; Jacobsen, S.U.; Soborg, B.; Bigaard, J. Using Facebook to increase coverage of HPV vaccination among Danish girls: An assessment of a Danish social media campaign. Vaccine 2020, 38, 4901–4908. [Google Scholar] [CrossRef]
- Fox, S. Health and Technology in the U.S. Pew Research Center, 2013. Available online: https://www.pewresearch.org/internet/2013/12/04/health-and-technology-in-the-u-s/ (accessed on 1 January 2021).
- Perrin, A.; Anderson, M. Share of U.S. adults using social media, including Facebook, is mostly unchanged since 2018. Pew Research Center, 10 April 2019. Available online: https://www.pewresearch.org/fact-tank/2019/04/10/share-of-u-s-adults-using-social-media-including-facebook-is-mostly-unchanged-since-2018/ (accessed on 25 August 2020).
- Jang, S.M.; McKeever, B.W.; McKeever, R.; Kim, J.K. From Social Media to Mainstream News: The Information Flow of the Vaccine-Autism Controversy in the US, Canada, and the UK. Health Commun. 2019, 34, 110–117. [Google Scholar] [CrossRef]
- Ortiz, R.R.; Smith, A.; Coyne-Beasley, T. A systematic literature review to examine the potential for social media to impact HPV vaccine uptake and awareness, knowledge, and attitudes about HPV and HPV vaccination. Hum. Vaccines Immunother. 2019, 15, 1465–1475. [Google Scholar] [CrossRef]
- Burki, T. The online anti-vaccine movement in the age of COVID-19. Lancet Digit. Health 2020, 2, e504–e505. [Google Scholar] [CrossRef]
- Luisi, M.L. From bad to worse II: Risk amplification of the HPV vaccine on Facebook. Vaccine 2021, 39, 303–308. [Google Scholar] [CrossRef]
- Massey, P.M.; Kearney, M.D.; Hauer, M.K.; Selvan, P.; Koku, E.; Leader, A.E. Dimensions of Misinformation About the HPV Vaccine on Instagram: Content and Network Analysis of Social Media Characteristics. J. Med Internet Res. 2020, 22, e21451. [Google Scholar] [CrossRef]
- Margolis, M.A.; Brewer, N.T.; Shah, P.D.; Calo, W.A.; Gilkey, M.B. Stories about HPV vaccine in social media, traditional media, and conversations. Prev. Med. 2019, 118, 251–256. [Google Scholar] [CrossRef]
- Pagoto, S.; Waring, M.E.; Xu, R. A Call for a Public Health Agenda for Social Media Research. J. Med Internet Res. 2019, 21, e16661. [Google Scholar] [CrossRef]
- Sundstrom, B.; Smith, E.; Delay, C.; Luque, J.S.; Davila, C.; Feder, B.; Paddock, V.; Poudrier, J.; Young Pierce, J.; Brandt, H.M. A reproductive justice approach to understanding women’s experiences with HPV and cervical cancer prevention. Soc. Sci. Med. 2019, 232, 289–297. [Google Scholar] [CrossRef]
- Sundstrom, B.; Aylor, E.; Cartmell, K.B.; Brandt, H.M.; Bryant, D.C.; Halbert, C.H.; Pierce, J.Y. Beyond the birds and the bees: A qualitative content analysis of online HPV vaccination communication. J. Commun. Healthc. 2018, 11, 205–214. [Google Scholar] [CrossRef]
- Cartmell, K.B.; Mzik, C.R.; Sundstrom, B.L.; Luque, J.S.; White, A.; Young-Pierce, J. HPV Vaccination Communication Messages, Messengers, and Messaging Strategies. J. Cancer Educ. 2018, 34, 1014–1023. [Google Scholar] [CrossRef]
- Neiger, B.L.; Thackeray, R.; van Wagenen, S.A.; Hanson, C.L.; West, J.H.; Barnes, M.D.; Fagen, M.C. Use of Social Media in Health Promotion. Health Promot. Pr. 2012, 13, 159–164. [Google Scholar] [CrossRef]
- Bonnevie, E.; Goldbarg, J.; Gallegos-Jeffrey, A.K.; Rosenberg, S.D.; Wartella, E.; Smyser, J. Content Themes and Influential Voices within Vaccine Opposition on Twitter, 2019. Am. J. Public Health 2020, 110, S326–S330. [Google Scholar] [CrossRef]
- Jamison, A.; Broniatowski, D.A.; Smith, M.C.; Parikh, K.S.; Malik, A.; Dredze, M.; Quinn, S.C. Adapting and Extending a Typology to Identify Vaccine Misinformation on Twitter. Am. J. Public Health 2020, 110, S331–S339. [Google Scholar] [CrossRef]
- Corbin, J.; Strauss, A. Basics of Qualitative Research: Techniques and Procedures for Developing Grounded Theory, 3rd ed.; Sage Publications: Thousand Oaks, CA, USA, 2008. [Google Scholar]
- Bogani, G.; Raspagliesi, F.; di Donato, V.; Brusadelli, C.; Guerrisi, R.; Pinelli, C.; Casarin, J.; Ghezzi, F.; del Fabro, A.; Ditto, A.; et al. Spotlight on the role of human papillomavirus vaccines. Gynecol. Oncol. 2021, 160, 346–350. [Google Scholar] [CrossRef]
- Luvero, D.; Lopez, S.; Bogani, G.; Raspagliesi, F.; Angioli, R. From the Infection to the Immunotherapy in Cervical Cancer: Can We Stop the Natural Course of the Disease? Vaccines 2020, 8, 597. [Google Scholar] [CrossRef]
Theme | Sample Post |
---|---|
Week 1 (June 5–8) | |
Introduction to HPV Vaccination NOW Social Media Campaign | About 14 million people, including teens, become infected with HPV each year. HPV infection can cause cervical, vaginal, and vulvar cancers in women and penile cancer in men. HPV can also cause anal cancer, throat cancer, and genital warts in both men and women. The good news is that you can get vaccinated against HPV and prevent cancer. Vaccines work! #2shots2stopCancer #HPVvaxNOW https://www.cdc.gov/hpv/parents/cancer.html (accessed on 1 January 2021) |
Week 2 (June 9–15) | |
About HPV Vaccination | Did you know? The HPV vaccine is for girls AND boys, ages 9–26. The Advisory Committee on Immunization Practices (ACIP) recommends a 2-dose schedule (0, 6–12 months) for HPV vaccination of girls and boys who initiate the vaccination series at ages 9 through 14 years. #2shots2stopCancer #HPVvaxNOW #OurMoment https://www.cdc.gov/hpv/parents/vaccine.html (accessed on 1 January 2021) |
Week 3 (June 16–22) | |
Focus on Family/Parents | As parents, you do everything you can to protect your children’s health for now and for the future. Today, there is a strong weapon to prevent several types of cancer in our kids: The HPV vaccine. #HPVvaxNOW #OurMoment https://www.cdc.gov/vaccines/parents/diseases/teen/hpv-indepth-color.pdf (accessed on 1 January 2021) |
Week 4 (June 23–29) | |
Focus on Clinicians | Clinicians: Providing personal examples of how you support vaccinations for your family members shows you believe they are important. Share how you recommended or administered HPV vaccine for your own children, grandchildren, nieces, or nephews. Sharing your personal experience may make parents more comfortable in their decision to vaccinate their child. #HPVvaxNOW #OurMoment https://www.cdc.gov/hpv/hcp/boosting-vacc-rates.html (accessed on 1 January 2021) |
Week 5 (June 30–July 6) | |
HPV Vaccination in South Carolina | Most parents choose the HPV vaccine for their children. In South Carolina, almost 60% of teens receive the first dose. To protect the next generation through herd immunity, we need to reach 80% of young adults. The HPV vaccination can protect a generation of South Carolina preteens and teens from cancers caused by HPV. #HPVvaxNOW #OurMoment https://www.cdc.gov/mmwr/volumes/67/wr/mm6733a1.htm (accessed on 1 January 2021) |
Week 6 (July 7–13) | |
Focus on Cervical Cancer | Eliminating cervical cancer depends on successful HPV vaccination and cervical screening initiatives. According to Professor Karen Canfell from the Cancer Council New South Wales, “We must be very clear about this: millions of women can be spared unnecessary, terrible suffering if HPV vaccines can be effectively deployed and scaled up globally.” https://www.theguardian.com/society/2019/feb/20/cervical-cancer-hpv-vaccine-screening-research?fbclid=IwAR30FdW4q8bgIM1k27ByhelsLb2lX9FS7DibQ2ZbopzhSLWBdjF3Bsno0Ec (accessed on 1 January 2021) |
Week 7 (July 14–20) | |
Focus on Head, Neck, and Throat cancers | Did you know about the link between HPV and head and neck cancers? Men are twice as likely to get head and neck cancers compared with women, but new cases of head and neck cancers in women are increasing. #HPVvaxNOW https://www.cdc.gov/cancer/headneck/ (accessed on January 1, 2021) |
Week 8 (July 21–27) | |
Focus on Survivor Stories | Check out these Cervivor Stories where survivors tell their stories to challenge the stigma of cervical cancer and build a movement to end cervical cancer. There is strength in stories. https://cervivor.org/stories/ (accessed on January 1, 2021) |
Week 9 (July 28-Aug 3) | |
Focus on Facts about HPV and Answering Tough Questions | The HPV vaccine protects fertility by preventing pre-cancerous cervical lesions and cervical cancer. Treatment of pre-cancerous lesions can sometimes lead to pregnancy loss, preterm delivery, low birthweight, or other complications in the future. In the United States alone, approximately 400,000 women present with abnormal Pap test results each year. Reducing pre-cancerous cells means that fewer women will have to experience the psychological and physical impact of treatment. #HPVvaxNOW #OurMoment http://www.euro.who.int/__data/assets/pdf_file/0010/356842/QA_HPV_General_EN.pdf?ua=1 (accessed on 1 January 2021) |
Week 10 (Aug. 4–10) | |
Focus on Activism (What you can do) | Social media makes a difference! A recent study in Pediatrics found that pregnant women who interacted with responsible vaccine information on social media were more likely to vaccinate their children on time. We all play an important role in increasing vaccine understanding and acceptance. |
Impressions | Reach | Engagement | |
---|---|---|---|
Week 1 (June 5–8) | |||
15,116 | 8590 | 146 | |
12,336 | N/A | 110 | |
Week 2 (June 9–15) | |||
25,413 | 11,755 | 221 | |
17,595 | N/A | 135 | |
Week 3 (June 16–22) | |||
23,467 | 11,696 | 278 | |
14,436 | N/A | 126 | |
Week 4 (June 23–29) | |||
23,682 | 11,108 | 85 | |
12,330 | N/A | 109 | |
Week 5 (June 30–July 6) | |||
25,799 | 11,792 | 111 | |
18,392 | N/A | 162 | |
Week 6 (July 7–13) | |||
14,263 | 9288 | 78 | |
18,219 | N/A | 174 | |
Week 7 (July 14–20) | |||
12,835 | 5359 | 91 | |
20,542 | N/A | 130 | |
Week 8 (July 21–27) | |||
17,001 | 5876 | 178 | |
20,313 | N/A | 125 | |
Week 9 (July 28–Aug 3) | |||
16,974 | 6248 | 102 | |
20,432 | N/A | 133 | |
Week 10 (Aug. 4–10) | |||
15,211 | 6118 | 91 | |
20,364 | N/A | 155 |
Ad Name | Text | Cost Per Result | Reach | Impressions | Spend |
---|---|---|---|---|---|
Parents Take Control (Graphic) | Parents: Take Control! Help your child live a happy and healthy life. | USD 6.28 | 6374 | 11.2 K | USD 40 |
* + Parents Take Control (Image) | USD 5.98 | 6684 | 12.2 K | USD 40 | |
Shape Their Future (Graphic) | You have the power to shape their future. Ask for the vaccine that prevents cancer. | USD 6.43 | 6221 | 10.5 K | USD 40 |
* + Shape Their Future (Image) | USD 6.17 | 6486 | 11.5 K | USD 40 | |
Safe and Effective (Graphic) | The HPV vaccine is safe and effective. | USD 5.73 | 6978 | 12.7 K | USD 40 |
* ^ Safe and Effective (Image) | USD 5.69 | 7024 | 13.2 K | USD 40 |
Impressions | Reach | Engagement | Clicks (Paid) | CTR * % | Cost-Per-Click USD | Followers | Spend USD | |
---|---|---|---|---|---|---|---|---|
Overall | ||||||||
188,196 | 33,951 | 1362 | 797 | 0.44 | 1.13 | 515 | 900.00 | |
182,700 | N/A | 1365 | 984 | 0.71 | 1.04 | 597 | 1019.69 |
Topic | Response * |
---|---|
Safety | The safety of HPV vaccination was tested in thousands of volunteers before the vaccines were approved. Over the last decade, more than 100 million doses have been distributed in the United States. The HPV vaccine has been carefully studied and has been shown to be safe, effective, and long-lasting. |
Side effects | The most common side effects after HPV vaccine are mild and include pain in the arm where the shot was given, fever, dizziness, and nausea. Approximately 100 million doses of HPV vaccine have been distributed in the U.S. since the vaccine was introduced, and no serious side effects have been linked to HPV vaccination. |
Effectiveness: Does the vaccine work? | Ongoing studies show that the HPV vaccination works very well. Since becoming available in 2006, this vaccine has already decreased HPV infection, genital warts, and precancers in young people. |
Effectiveness: Risk | HPV is so common that almost everyone will be infected at some point in their lives. Most parents in South Carolina choose the HPV vaccine for their children. Almost 60% of teens in our state receive the first dose. The HPV vaccine prevents six cancers and other diseases in both girls and boys. |
Infertility | Clinical trials before the first HPV vaccine was licensed in 2006 and safety monitoring and studies since its introduction have confirmed that the vaccine does not cause any reproductive problems in women. |
Sexual activity: Promotion | Studies show that HPV vaccination does not lead to increased sexual activity or sex at a younger age. Getting the HPV vaccine before your child is exposed to the virus can prevent 6 HPV-related cancers. Even someone who waits until marriage for sex and only has one partner can still get HPV. The HPV vaccine is recommended for boys and girls when they are 11 to 12 years old. The HPV vaccine is more effective when given at this age rather than waiting until a child is older. |
Sexual activity: Wait until marriage | We know that all parents in South Carolina want to do what is best for their children and their families. HPV is so common that almost everyone will be infected at some point in their lives. Anyone who is sexually active can get HPV, even if you have had sex with only one person. The HPV vaccine prevents 6 HPV-related cancers in girls and boys. |
Sexual activity: Condom | Using condoms the right way every time you have sex can lower your chances of getting HPV. But HPV can infect areas not covered by a condom—So condoms may not fully protect against getting HPV. The HPV vaccine prevents 6 HPV-related cancers in girls and boys. |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Sundstrom, B.; Cartmell, K.B.; White, A.A.; Well, H.; Pierce, J.Y.; Brandt, H.M. Correcting HPV Vaccination Misinformation Online: Evaluating the HPV Vaccination NOW Social Media Campaign. Vaccines 2021, 9, 352. https://doi.org/10.3390/vaccines9040352
Sundstrom B, Cartmell KB, White AA, Well H, Pierce JY, Brandt HM. Correcting HPV Vaccination Misinformation Online: Evaluating the HPV Vaccination NOW Social Media Campaign. Vaccines. 2021; 9(4):352. https://doi.org/10.3390/vaccines9040352
Chicago/Turabian StyleSundstrom, Beth, Kathleen B. Cartmell, Ashley A. White, Henry Well, Jennifer Young Pierce, and Heather M. Brandt. 2021. "Correcting HPV Vaccination Misinformation Online: Evaluating the HPV Vaccination NOW Social Media Campaign" Vaccines 9, no. 4: 352. https://doi.org/10.3390/vaccines9040352
APA StyleSundstrom, B., Cartmell, K. B., White, A. A., Well, H., Pierce, J. Y., & Brandt, H. M. (2021). Correcting HPV Vaccination Misinformation Online: Evaluating the HPV Vaccination NOW Social Media Campaign. Vaccines, 9(4), 352. https://doi.org/10.3390/vaccines9040352